Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection.
Matthew A GreenwaldSuzanne L MeinigLucas M PlottCristian RocaMatthew G HiggsNicholas P VitkoMatthew Raymond MarkovetzKaitlyn R RouillardJerome CarpenterMehmet KesimerDavid B HillJonathan C SchislerMatthew C WolfgangPublished in: mBio (2024)
model for therapeutic development.